Figure 5
From: TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole
Relative TDP-43 expression under treatment with compounds riluzole, auranofin and chelerythrine. N2a cells fixed with 4% paraformaldehyde after treatment with riluzole (A + B), auranofin (C + D) and chelerythrine (E + F) in different concentrations (1.6–62.5 µM) and stained with anti-TDP-43 and DAPI. Results described in % of untreated reference for each compound concentration (1.6–62.5 µM; B,D + F), Mean ± SD, Mann-Whitney-U-Test, **p < 0.01, n = 6.
